Obesity trials in Brazil

In Brazil 42 Also abroad 1939

42 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Goiânia, Natal, Porto Alegre, São José do Rio Preto, São Paulo
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Aracaju, Goiânia, Porto Alegre, Rio de Janeiro, São José do Rio Preto, São Paulo
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Where
Belo Horizonte, Campinas, São Paulo
Age
18 years and over
People
500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Brasília, Campinas, São José do Rio Preto, São Paulo
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Not yet taking people in Brazil
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Where
Belo Horizonte, Bragança Paulista, Campinas, Curitiba, São Paulo
Age
18 years and over
People
1,408 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07919405
Phase 3Taking people
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Where
Brasília, Caxias do Sul, São Paulo
Age
6 years to 17 years
People
125 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06672549
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Aracaju, Brasília, Campinas, Caxias do Sul, Curitiba, Juiz de Fora, Porto Alegre, Ribeirão Preto, Salvador, Santo André, São Paulo, Vitória, Votuporanga
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 3Taking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Aracaju, Brasília, Campinas, Caxias do Sul, Curitiba, Juiz de Fora, Porto Alegre, Ribeirão Preto, Salvador, Santo André, São Paulo, Vitória, Votuporanga
Age
18 years to 70 years
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Where
Campinas, Marília, Porto Alegre, Recife, Rio de Janeiro, Santo André, São Paulo
Age
18 years and over
People
800 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Where
Curitiba, Fortaleza, São Paulo, Vitória, Votuporanga
Age
18 years and over
People
900 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
Campinas, Curitiba, Porto Alegre, Rio de Janeiro, São Paulo
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Not yet taking people in Brazil
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Aracaju, Brasília, Campinas, Curitiba, Fortaleza, Porto Alegre, Recife, Rio de Janeiro, São Paulo, Vitória
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
No phaseNot yet taking people in Brazil
Effects of Taurine Supplementation and Morning or Evening High-intensity Exercise on Circadian Clock Genes and Inflammatory Parameters in Adult Women With Obesity
Where
Ribeirão Preto
Age
18 years to 45 years
People
60
Run by
University of Sao Paulo
See details and how to joinNCT07910747
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Belo Horizonte, Brasília, Campinas, Curitiba, Natal, Porto Alegre, Rio de Janeiro, São José dos Campos, São Paulo
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Aracaju, Belo Horizonte, Campinas, Curitiba, Goiânia, Marília, Porto Alegre, Ribeirão Preto, Rio de Janeiro, Salvador, Santo André, São José do Rio Preto, São José dos Campos, São Paulo, Tatuí, Vitória
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
No phaseTaking people
Multimodal Intervention for Weight Management and Health in the Elderly Population
Where
Maringá
Age
60 years and over
People
54
Run by
Universidade Cesumar (UNICESUMAR)
See details and how to joinNCT07820774
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Belém, Brasília, Campinas, Curitiba, Fortaleza, Porto Alegre, São José dos Campos, São Paulo
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 3Not yet taking people in Brazil
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Bairro Rodolfo Teófilo, Fortaleza, Botucatu, Bragança Paulista, Campinas, Curitiba, Goiânia, Manaus, Marília, Poços de Caldas, Porto Alegre, São José dos Campos, Sao Jose Rio Preto, São Paulo
Age
45 years to 64 years
People
8,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
No phaseNot yet taking people in Brazil
WB-EMS Combined With Nutritional Guidance for a High-Protein Diet on Body Composition, Muscle Function, Psychological and Functional Outcomes in Older Adults With Excess Adiposity
Where
Maringá
Age
60 years and over
People
36
Run by
Universidade Cesumar (UNICESUMAR)
See details and how to joinNCT07859072
No phaseTaking people
Effects of a Dietary Intervention Based on the Dietary Guidelines for the Brazilian Population on the Reduction of Menopausal Symptoms in Overweight and Obese Women
Where
Porto Alegre
Age
40 years to 65 years
People
74
Run by
Federal University of Health Science of Porto Alegre
See details and how to joinNCT07822230
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Brasília, Campinas, Fortaleza, Marília, Porto Alegre, Rio de Janeiro, São Paulo
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
No phaseEnrolling by invitation
Cities for Better Health Childhood Obesity Prevention Initiative
Where
Campinas
Age
6 years to 13 years
People
36,000 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT06855563
No phaseTaking people
Acute Effects of Isoenergetic HIIE vs. MICE on Key Parameters of Fat Mass Loss in Young Females With Overweight or Obesity
Where
São Paulo
Age
20 years to 45 years
People
15
Run by
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
See details and how to joinNCT06868862
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Aracaju, Belo Horizonte, Blumenau, Bragança Paulista, Campinas, Goiânia/GO, Maceió, Marília/SP, Porto Alegre, Recife, Ribeirão Preto, Rio Branco, São Caetano Do Sul / SP, São José dos Campos, Sao Jose Rio Preto, São Paulo, Tatuí, Uberlândia
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseNot yet taking people in Brazil
Rosuvastatin and Losartan Pharmacokinetics After Bariatric Surgery
Where
Ribeirão Preto
Age
18 years to 65 years
People
60
Run by
Hospital das Clínicas de Ribeirão Preto
See details and how to joinNCT07748273